Literature DB >> 17197142

[Imported severe malaria in adults: a retrospective study of ten cases admitted to intensive care units in Casablanca].

B Charra1, M Sodqi, O Sandali, H Nejmi, A Hachimi, H Ezzouine, A Benslama, H Himmich, S Motaouakkil.   

Abstract

INTRODUCTION: We report a retrospective study in the medical intensive care unit of the Casablanca Ibn-Rochd University hospital.
MATERIAL AND METHODS: All patients over 14 years of age with falciparum malaria, who were admitted to ICUs between 1996 and 2001, were included. The main epidemiological features, criteria of admission, treatment, and outcome were investigated.
RESULTS: Ten patients were included for severe imported malaria. The mean age was 32+/-4 years. All patients had acquired falciparum malaria in sub-Saharan Africa. Chemoprophylaxis was inadequate in all patients. The mean time from symptom onset to treatment initiation was 9+/-2 days. Criteria of admission were impaired consciousness (7), acute renal failure (4), and respiratory distress (3). The most worrying factors were the severity of consciousness disorders, the acute respiratory distress syndrome, the metabolic acidosis, and the refractory shock. All patients presented with nosocomial respiratory infection related to Gram-negative bacilli, in the evolution. All patients received quinine therapy with loading dose and symptomatic treatment. Five patients died.
CONCLUSION: The lethality of severe imported malaria is still high despite optimal management in ICUs. Improving chemoprophylaxis and an earlier diagnosis may reduce significantly the mortality rate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17197142     DOI: 10.1016/j.medmal.2006.09.006

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  1 in total

1.  [Severe imported malaria in adults: a retrospective study of thirteen cases admitted to the Intensive Care Unit in Marrakech].

Authors:  El Mostafa El Mezouari; Ayoub Belhadj; Mohamed Ziani; Mohamed Boughanem; Redouane Moutaj
Journal:  Pan Afr Med J       Date:  2016-11-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.